跳到正文

Rock Springs Capital Management LP 13F 持仓 · 2026年Q2

Rock Springs Capital Management 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 104 只证券,申报市值合计 20.49 亿美元。前几大持仓:RVMD(10.10%)、TVTX(6.04%)、LLY(5.78%)。本季前 25 大持仓中:新建仓 1 只、增持 10 只、减持 12 只。

排名代码公司市值占组合股数变动
1RVMDREVOLUTION MEDICINES INC$207.0M10.10%1.1M减持
2TVTXTRAVERE THERAPEUTICS INC$123.8M6.04%2.2M增持
3LLYELI LILLY & CO$118.4M5.78%98,700持平
4MDGLMADRIGAL PHARMACEUTICALS INC$94.0M4.59%174,999增持
5MIRMMIRUM PHARMACEUTICALS INC$93.4M4.56%798,145减持
6RYTMRHYTHM PHARMACEUTICALS INC$76.9M3.75%692,598增持
7KYMRKYMERA THERAPEUTICS INC$52.0M2.54%453,156减持
8ARGXARGENX SE$48.9M2.39%52,750减持
9ASNDASCENDIS PHARMA A/S$45.0M2.20%168,750新建仓
10XENEXENON PHARMACEUTICALS INC$41.3M2.01%683,907减持
11SRRKSCHOLAR ROCK HLDG CORP$39.3M1.92%715,452减持
12INSMINSMED INC$38.6M1.88%362,150增持
13PENPENUMBRA INC$36.5M1.78%115,750减持
14GPCRSTRUCTURE THERAPEUTICS INC$34.4M1.68%640,317增持
15RAREULTRAGENYX PHARMACEUTICAL IN$32.3M1.58%967,855减持
16IRTCIRHYTHM HOLDINGS INC$32.1M1.57%269,650增持
17ISRGINTUITIVE SURGICAL INC$30.4M1.48%76,460减持
18AGLAGILON HEALTH INC$28.1M1.37%262,600增持
19UNHUNITEDHEALTH GROUP INC$26.5M1.29%63,750增持
20CLDXCELLDEX THERAPEUTICS INC NEW$26.0M1.27%699,146增持
21ERASERASCA INC$25.7M1.25%1.4M增持
22NBIXNEUROCRINE BIOSCIENCES INC$24.4M1.19%144,750减持
23ELVNENLIVEN THERAPEUTICS INC$23.6M1.15%464,625减持
24THCTENET HEALTHCARE CORP$23.4M1.14%125,000持平
25DXCMDEXCOM INC$23.1M1.13%343,000减持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR